<DOC>
	<DOCNO>NCT01776528</DOCNO>
	<brief_summary>The purpose study determine safety tolerability NGM282 , single dose multiple dos , normal healthy adult participant .</brief_summary>
	<brief_title>Phase 1 SAD MAD Study NGM282 Healthy Adult Participants</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Males female , 18 65 year age , inclusive BMI range 2035 kg/m2 , inclusive SAD Module , 2535 kg/m2 , inclusive MAD Module Screening ; In good health , determine clinically significant finding medical history , physical exam , 12 lead ECG , clinical laboratory finding , vital sign Screening Day 1 Significant history clinical manifestation significant metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , GI , neurological , psychiatric disorder ( determined PI ) History significant hypersensitivity , intolerance , allergy drug compound , food , substance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>